The Contribution of Heels for Walking Quality Among Children With Muscular Dystrophy

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified April 2013 by Alyn Pediatric & Adolecent Rehabilitation Center
Sponsor:
Information provided by (Responsible Party):
Alyn Pediatric & Adolecent Rehabilitation Center
ClinicalTrials.gov Identifier:
NCT01638169
First received: July 9, 2012
Last updated: April 23, 2013
Last verified: April 2013
  Purpose

During the stand phase the DMD foot is too plantarflexed in addition patients adopt a higher flexion and abduction of the hip in order to advance the swinging limb. The aim of this work is to assess the immediate contribution of heels for these walking disturbance in children with muscular dystrophy disease.


Condition Intervention
Step Time and Length
Symmetry
Step Time and Length Variability
Heart Rate
Gait Velocity
Device: adding a heel

Study Type: Observational
Study Design: Observational Model: Case-Only

Resource links provided by NLM:


Further study details as provided by Alyn Pediatric & Adolecent Rehabilitation Center:

Primary Outcome Measures:
  • gait parameters [ Time Frame: pre and post heels adj. ] [ Designated as safety issue: No ]

Estimated Enrollment: 20
Study Start Date: May 2013
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
20 children with DMD Device: adding a heel
walking with and without heels on the gaitrite system

  Eligibility

Ages Eligible for Study:   6 Years to 15 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

children with DMD age >6 yrs walk without heel strike

Criteria

Inclusion Criteria:

  • age >6 yrs
  • walk without heel strike

Exclusion Criteria:

  • cannot understand simple instructions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01638169

Locations
Israel
Alyn Not yet recruiting
Jerusalem, Israel, 90190
Contact: Michal Katz, PhD    97226494283    mkatz@alyn.org   
Sponsors and Collaborators
Alyn Pediatric & Adolecent Rehabilitation Center
  More Information

No publications provided

Responsible Party: Alyn Pediatric & Adolecent Rehabilitation Center
ClinicalTrials.gov Identifier: NCT01638169     History of Changes
Other Study ID Numbers: 920100239
Study First Received: July 9, 2012
Last Updated: April 23, 2013
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Muscular Dystrophies
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on August 19, 2014